HORMONAL THERAPY OF WOMEN FOR METASTATIC BREAST CARCINOMA. VI. 17-BETA-HYDROXY-17-METHYL-2-OXA-5-ALPHA-ANDROSTAN-3-ONE (NSC-67068).
D045930:Anabolic Agents; D001943:Breast Neoplasms; D013196:Dihydrotestosterone / Q000031:analogs & derivatives; D005767:Gastrointestinal Diseases; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D010121:Oxytocin / Q000031:analogs & derivatives; D013256:Steroids; D014116:Toxicology
D045930:Anabolic Agents; D013256:Steroids; D013196:Dihydrotestosterone; C038097:androstan-3-one; D010121:Oxytocin; C015692:oxytocin, Asp(5)-
ANABOLIC STEROIDS; BREAST NEOPLASMS; GASTROINTESTINAL DISEASES; NEOPLASM THERAPY; TOXICOLOGIC REPORT